Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE36.3200
- TODAY'S CHANGE (%)-0.2800 (-0.7650%)
- Bid / Lots36.2800/ 3
- Ask / Lots36.4000/ 3
- Open / Previous Close36.7100 / 36.6000
- Day Range
- 52 Week Range
- Volume255,465
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 3020 | 36.535 |
| 09:34 ET | 400 | 36.01 |
| 09:36 ET | 1300 | 35.76 |
| 09:38 ET | 300 | 36.25 |
| 09:39 ET | 17811 | 36.26 |
| 09:41 ET | 8000 | 36.205 |
| 09:43 ET | 26999 | 36.04 |
| 09:45 ET | 583 | 36.365 |
| 09:48 ET | 1620 | 36.295 |
| 09:50 ET | 2542 | 36.42 |
| 09:52 ET | 1039 | 36.3725 |
| 09:54 ET | 6700 | 36.49 |
| 09:56 ET | 1198 | 36.5 |
| 09:57 ET | 100 | 36.46 |
| 09:59 ET | 2836 | 36.41 |
| 10:01 ET | 773 | 36.47 |
| 10:03 ET | 3663 | 36.24 |
| 10:06 ET | 100 | 36.13 |
| 10:08 ET | 1600 | 36.095 |
| 10:10 ET | 1400 | 35.93 |
| 10:12 ET | 900 | 35.85 |
| 10:14 ET | 600 | 35.76 |
| 10:15 ET | 100 | 35.67 |
| 10:19 ET | 3353 | 36.03 |
| 10:21 ET | 800 | 35.975 |
| 10:24 ET | 2200 | 36.3 |
| 10:26 ET | 400 | 36.42 |
| 10:28 ET | 208 | 36.225 |
| 10:30 ET | 100 | 36.19 |
| 10:32 ET | 200 | 36.15 |
| 10:33 ET | 300 | 36.225 |
| 10:35 ET | 400 | 36.225 |
| 10:37 ET | 200 | 36.225 |
| 10:39 ET | 2036 | 36.51 |
| 10:42 ET | 1660 | 36.47 |
| 10:44 ET | 2812 | 36.195 |
| 10:48 ET | 100 | 36.13 |
| 10:51 ET | 743 | 36.06 |
| 10:53 ET | 600 | 36.055 |
| 10:57 ET | 1078 | 35.9801 |
| 11:00 ET | 1700 | 36.13 |
| 11:02 ET | 600 | 36.13 |
| 11:04 ET | 585 | 36.145 |
| 11:06 ET | 200 | 36.24 |
| 11:08 ET | 1838 | 36.18 |
| 11:09 ET | 600 | 36.2 |
| 11:11 ET | 100 | 36.25 |
| 11:13 ET | 300 | 36.25 |
| 11:15 ET | 100 | 36.18 |
| 11:18 ET | 1660 | 36.3 |
| 11:20 ET | 500 | 36.375 |
| 11:22 ET | 2876 | 36.3 |
| 11:27 ET | 2200 | 36.34 |
| 11:29 ET | 1100 | 36.33 |
| 11:31 ET | 800 | 36.33 |
| 11:33 ET | 1600 | 36.33 |
| 11:36 ET | 4947 | 36.3 |
| 11:38 ET | 910 | 36.365 |
| 11:40 ET | 806 | 36.35 |
| 11:44 ET | 600 | 36.44 |
| 11:45 ET | 3278 | 36.27 |
| 11:47 ET | 500 | 36.19 |
| 11:49 ET | 400 | 36.13 |
| 11:51 ET | 100 | 36.19 |
| 11:54 ET | 900 | 36.13 |
| 11:56 ET | 2530 | 36.28 |
| 12:00 ET | 300 | 36.33 |
| 12:02 ET | 100 | 36.4 |
| 12:03 ET | 100 | 36.37 |
| 12:05 ET | 400 | 36.38 |
| 12:07 ET | 100 | 36.39 |
| 12:09 ET | 276 | 36.436 |
| 12:12 ET | 300 | 36.45 |
| 12:14 ET | 100 | 36.45 |
| 12:16 ET | 900 | 36.52 |
| 12:18 ET | 2884 | 36.76 |
| 12:20 ET | 300 | 36.645 |
| 12:21 ET | 200 | 36.75 |
| 12:23 ET | 1390 | 36.93 |
| 12:25 ET | 800 | 36.94 |
| 12:27 ET | 300 | 36.855 |
| 12:30 ET | 772 | 36.95 |
| 12:32 ET | 3689 | 36.64 |
| 12:34 ET | 200 | 36.615 |
| 12:36 ET | 100 | 36.58 |
| 12:38 ET | 700 | 36.565 |
| 12:39 ET | 800 | 36.45 |
| 12:41 ET | 200 | 36.45 |
| 12:43 ET | 500 | 36.53 |
| 12:45 ET | 1000 | 36.45 |
| 12:48 ET | 1391 | 36.415 |
| 12:50 ET | 1100 | 36.49 |
| 12:52 ET | 500 | 36.43 |
| 12:54 ET | 200 | 36.47 |
| 12:56 ET | 300 | 36.47 |
| 12:57 ET | 400 | 36.45 |
| 12:59 ET | 6023 | 36.49 |
| 01:01 ET | 2633 | 36.38 |
| 01:03 ET | 711 | 36.38 |
| 01:06 ET | 488 | 36.36 |
| 01:08 ET | 672 | 36.41 |
| 01:10 ET | 400 | 36.38 |
| 01:14 ET | 1200 | 36.23 |
| 01:15 ET | 200 | 36.18 |
| 01:17 ET | 200 | 36.19 |
| 01:19 ET | 100 | 36.235 |
| 01:21 ET | 1075 | 36.15 |
| 01:24 ET | 1000 | 36.245 |
| 01:26 ET | 200 | 36.245 |
| 01:28 ET | 700 | 36.2 |
| 01:30 ET | 200 | 36.31 |
| 01:32 ET | 300 | 36.18 |
| 01:33 ET | 436 | 36.2 |
| 01:35 ET | 4722 | 36.305 |
| 01:37 ET | 1800 | 36.19 |
| 01:39 ET | 100 | 36.16 |
| 01:42 ET | 600 | 36.16 |
| 01:44 ET | 205 | 36.14 |
| 01:46 ET | 3061 | 36.32 |
| 01:48 ET | 300 | 36.42 |
| 01:50 ET | 449 | 36.31 |
| 01:51 ET | 100 | 36.3 |
| 01:53 ET | 732 | 36.32 |
Today
Jun 5, 2024
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
May 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 2.8B | -13.4x | --- |
Structure Therapeutics Inc | 2.8B | -20.6x | --- |
Geron Corp | 2.8B | -12.8x | --- |
SpringWorks Therapeutics Inc | 2.7B | -7.1x | --- |
Biohaven Ltd | 2.9B | -4.8x | --- |
MoonLake Immunotherapeutics | 2.6B | -52.8x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -13.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
